BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9739193)

  • 1. Cellular autoimmunity to retinal specific antigens in Behçet's disease.
    Hamzaoui K; Mili Boussen E; Hamzaoui A; Ouertani A; Chabbou A; Ayed K
    Tunis Med; 1998 Apr; 76(4):66-70. PubMed ID: 9739193
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease.
    Yamamoto JH; Minami M; Inaba G; Masuda K; Mochizuki M
    Br J Ophthalmol; 1993 Sep; 77(9):584-9. PubMed ID: 8218058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet's disease.
    Okunuki Y; Usui Y; Takeuchi M; Kezuka T; Hattori T; Masuko K; Nakamura H; Yudoh K; Usui M; Nishioka K; Kato T
    Exp Eye Res; 2007 May; 84(5):823-31. PubMed ID: 17343851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cellular immunoreaction to S-antigen in patients with uveitis and optic neuritis].
    Ren PX
    Zhonghua Yan Ke Za Zhi; 1993 May; 29(3):135-7. PubMed ID: 8223035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological study of endogenous uveitis. I. Dynamic study of autoimmunoreaction].
    Zhang MD; Huang SR
    Zhonghua Yan Ke Za Zhi; 1991 May; 27(3):165-8. PubMed ID: 1914710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte responses to peptide M and to retinal S-antigen in uveitis patients.
    Hirose S; Donoso LA; Shinohara T; Palestine AG; Nussenblatt RB; Gery I
    Jpn J Ophthalmol; 1990; 34(3):298-305. PubMed ID: 1706787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological studies on Behçet's and Harada's diseases. I. Cell-mediated immunity in Behçet's and Harada's diseases. II. HL-A antigens associated with Behçet's disease.
    Sugiura S; Sanefuji M; Ohno S
    Mod Probl Ophthalmol; 1976; 16():267-78. PubMed ID: 1250232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.
    Stanford M; Whittall T; Bergmeier LA; Lindblad M; Lundin S; Shinnick T; Mizushima Y; Holmgren J; Lehner T
    Clin Exp Immunol; 2004 Jul; 137(1):201-8. PubMed ID: 15196263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective determination of T-cell responses to S-antigen in Behçet's disease patients and controls.
    de Smet MD; Dayan M
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3480-4. PubMed ID: 11006242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses to retinal autoantigens and peptides in equine recurrent uveitis.
    Deeg CA; Kaspers B; Gerhards H; Thurau SR; Wollanke B; Wildner G
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):393-8. PubMed ID: 11157872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human S-antigen determinant recognition in uveitis.
    de Smet MD; Bitar G; Mainigi S; Nussenblatt RB
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3233-8. PubMed ID: 11726628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological findings in human beings with autoimmune uveitis.
    Alonso A; Bearra A; Scavini LM; Rodríguez SM
    Allergol Immunopathol (Madr); 1988; 16(6):417-20. PubMed ID: 3242381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
    Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of the general immune status and specific immune responsiveness to retinal-(S)-antigen in patients with chronic posterior uveitis.
    Froebel KS; Armstrong SS; Cliffe AM; Urbaniak SJ; Forrester JV
    Eye (Lond); 1989; 3 ( Pt 3)():263-70. PubMed ID: 2612670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis.
    Kurhan-Yavuz S; Direskeneli H; Bozkurt N; Ozyazgan Y; Bavbek T; Kazokoglu H; Eksioglu-Demiralp E; Wildner G; Diedrichs-Möhring M; Akoglu T
    Clin Exp Immunol; 2000 Apr; 120(1):162-6. PubMed ID: 10759778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease.
    Yasuoka H; Okazaki Y; Kawakami Y; Hirakata M; Inoko H; Ikeda Y; Kuwana M
    Arthritis Rheum; 2004 Nov; 50(11):3658-62. PubMed ID: 15529349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human retinal S-antigen: T cell epitope mapping in posterior uveitis patients.
    Rai G; Saxena S; Kumar H; Singh VK
    Exp Mol Pathol; 2001 Apr; 70(2):140-5. PubMed ID: 11263956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological study of Behcet's disease].
    Kawai K; Masuda K; Akimoto T
    Bull Soc Pathol Exot Filiales; 1978; 71(2):221-6. PubMed ID: 311255
    [No Abstract]   [Full Text] [Related]  

  • 19. [Humoral and cellular immune responses to retinal S-antigen in uveitis patients].
    Xie CF
    Zhonghua Yan Ke Za Zhi; 1993 May; 29(3):131-4. PubMed ID: 8223034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe retinochoroidopathy: variations of humoral and cellular immunity to S-antigen in a longitudinal study.
    Jobin D; Thillaye B; de Kozak Y; Sainte-Laudy J; Faure JP; Le Hoang P
    Curr Eye Res; 1990; 9 Suppl():91-6. PubMed ID: 2384017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.